Affinity Asset Advisors, LLC Mirum Pharmaceuticals, Inc. Transaction History
Affinity Asset Advisors, LLC
- $579 Million
- Q3 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 75,000 shares of MIRM stock, worth $3.13 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
75,000
Previous 155,000
51.61%
Holding current value
$3.13 Million
Previous $5.3 Million
44.8%
% of portfolio
0.51%
Previous 0.72%
Shares
7 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$274 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$187 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$144 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$135 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$128 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.53B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...